99 related articles for article (PubMed ID: 16080036)
1. AACR - 91st meeting. Interview with Dr James M Pluda.
Worker C
IDrugs; 2000 Jul; 3(7):726-9. PubMed ID: 16080036
[TBL] [Abstract][Full Text] [Related]
2. Promising new agents under development by the Division of Cancer Treatment, Diagnosis, and Centers of the National Cancer Institute.
Christian MC; Pluda JM; Ho PT; Arbuck SG; Murgo AJ; Sausville EA
Semin Oncol; 1997 Apr; 24(2):219-40. PubMed ID: 9129691
[TBL] [Abstract][Full Text] [Related]
3. Anti-angiogenic drugs: from bench to clinical trials.
Quesada AR; Muñoz-Chápuli R; Medina MA
Med Res Rev; 2006 Jul; 26(4):483-530. PubMed ID: 16652370
[TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
5. AACR -91st meeting. Interview with Dr Lars Breimer.
Worker C
IDrugs; 2000 Jul; 3(7):723-5. PubMed ID: 16080035
[TBL] [Abstract][Full Text] [Related]
6. Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Ramsey S; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Davidson NE; Schilsky RL; Lichter AS;
J Clin Oncol; 2008 Jan; 26(2):313-25. PubMed ID: 18086794
[TBL] [Abstract][Full Text] [Related]
7. Endostatin (EntreMed).
Grosios K
IDrugs; 2000 Jul; 3(7):799-810. PubMed ID: 16080055
[TBL] [Abstract][Full Text] [Related]
8. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
Otrock ZK; Mahfouz RA; Makarem JA; Shamseddine AI
Blood Cells Mol Dis; 2007; 39(2):212-20. PubMed ID: 17553709
[TBL] [Abstract][Full Text] [Related]
9. Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
Broxterman HJ; Georgopapadakou NH
Drug Resist Updat; 2005 Aug; 8(4):183-97. PubMed ID: 16154800
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis--a new target for future therapy.
Pandya NM; Dhalla NS; Santani DD
Vascul Pharmacol; 2006 May; 44(5):265-74. PubMed ID: 16545987
[TBL] [Abstract][Full Text] [Related]
11. NCI-EORTC-AACR--11th Symposium on New Drugs in Cancer Therapy: Gene therapy and new drugs. 7-10 November 2000, Amsterdam, The Netherlands.
Niculescu-Duvaz I
IDrugs; 2001 Feb; 4(2):145-7. PubMed ID: 16032472
[TBL] [Abstract][Full Text] [Related]
12. Review of the effects of anti-angiogenic compounds on the epiphyseal growth plate.
Hall AP; Westwood FR; Wadsworth PF
Toxicol Pathol; 2006; 34(2):131-47. PubMed ID: 16537292
[TBL] [Abstract][Full Text] [Related]
13. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
14. [Anti-angiogenic drugs].
Sato Y
Gan To Kagaku Ryoho; 2009 Jul; 36(7):1072-5. PubMed ID: 19620794
[TBL] [Abstract][Full Text] [Related]
15. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
Takakura N
Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
[TBL] [Abstract][Full Text] [Related]
16. American Association for Cancer Research--90th annual meeting. 10-14 April 1999, Philadelphia, PA, USA.
Boven E
IDrugs; 1999 Jun; 2(6):530-3. PubMed ID: 16127610
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
18. The NCI-EORTC Symposia on New Drugs in Cancer Therapy: A Brief History.
Krul MR
Oncologist; 1998; 3(4):269-270. PubMed ID: 10388114
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets and cancer therapeutics: discovery, development & clinical validation--AACR-NCI-EORTC international conference.
Orr RM
IDrugs; 2000 Feb; 3(2):167-9. PubMed ID: 16107931
[TBL] [Abstract][Full Text] [Related]
20. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
